Depression News and Research

Latest Depression News and Research

Democrats plan to expand Medicare hearing benefits. What can consumers expect?

President Joe Biden's mammoth domestic spending bill would add hearing benefits to the traditional Medicare program — one of three major new benefits Democrats had sought.

5 Nov 2021

APOL1 variant risk may extend to poorer outcomes from SARS-CoV-2 infection

Now, a new study published on the medRxiv* preprint server tests the hypothesis that adverse COVID-19 outcomes are associated with the variants of the APOL1 gene.

4 Nov 2021

Study finds significant increase in cannabis use disorder during pregnancy

As more states legalize cannabis (now 37) for medical or recreational purposes its use during pregnancy is increasing, along with the potential for abuse or dependence.

3 Nov 2021

Study shows aberrant changes over time in the brains of people with bipolar disorder

Bipolar disorder (BD) is a debilitating psychiatric disorder characterized by fluctuating periods of depression and mania.

3 Nov 2021

Study finds link between prior poor mental health and higher COVID-19 infection rates

At the height of the pandemic, news and policy media focused on how the COVID-19 pandemic was contributing to poor mental health, a hypothesis confirmed by several studies.

2 Nov 2021

Study finds high levels of anxiety, depression among medical doctors during COVID-19 pandemic

High levels of anxiety and depression among medical doctors have been recorded in a new cross-country study that finds Italian doctors most likely to have experienced mental health symptoms during the pandemic.

2 Nov 2021

NIH to support a four-year study on long-term effects of COVID-19 in pregnancy

The National Institutes of Health will support a four-year follow-up study on the potential long-term effects of COVID-19 on women infected with SARS-CoV-2 during pregnancy.

2 Nov 2021

The impacts of the SARS-CoV-2 pandemic on digestive health

The UEG Public Affairs Committee has published a position paper to educate policymakers, patients, healthcare professionals, and the general public about the impacts of the COVID-19 pandemic on digestive health.

2 Nov 2021

Merging AI with targeted electrical brain stimulation to improve specific human brain functions

In a pilot human study, researchers from the University of Minnesota Medical School and Massachusetts General Hospital show it is possible to improve specific human brain functions related to self-control and mental flexibility by merging artificial intelligence with targeted electrical brain stimulation.

1 Nov 2021

Factors predicting cognitive symptoms in long COVID

The researchers focused on finding risk factors for long-term symptom occurrence and severity, with special attention to cognitive impairment.

1 Nov 2021

Stanford neuromodulation therapy causes remission in almost 80% of patients with severe depression

A new type of magnetic brain stimulation brought rapid remission to almost 80% of participants with severe depression in a study conducted at the Stanford University School of Medicine.

30 Oct 2021

Researchers receive $9.1 million grant to study resilience in older adults before and during the pandemic

The National Institute on Aging of the National Institutes of Health has awarded researchers at Washington University School of Medicine in St. Louis a five-year, $9.1 million grant to study resilience in older adults before and during the COVID-19 pandemic, as well as the pandemic's cognitive and emotional effects on older adults.

30 Oct 2021

Women in the military face a considerable risk of emotional bullying, sexual harassment and physical assault

Women serving in the UK military face a considerable risk of emotional bullying, sexual harassment and physical assault, which can have a serious and long-lasting impact on their mental health and wellbeing, finds research published online in the journal BMJ Military Health.

30 Oct 2021

Magnus Medical receives FDA's Breakthrough Device Designation for rapid-acting technology to treat major depression

Magnus Medical, Inc., a medical device company, today announced that the U.S. Food & Drug Administration (FDA) has granted the company Breakthrough Device Designation for its individualized, rapid-acting, non-invasive neurostimulation technology designed to treat major depressive disorder (MDD) in people who have not improved sufficiently from antidepressant medication or other treatments.

29 Oct 2021

Review finds great resilience in mental health during during COVID-19 pandemic

Despite a significant but small increase in mental health symptoms early on in the COVID-19 pandemic, overall there was great resilience in mental health during 2020, University of Liverpool researchers have found.

28 Oct 2021

Using fluvoxamine to treat COVID-19 patients reduces the need for prolonged hospitalization, trial shows

The results of a new randomized clinical trial, published in The Lancet Global Health, have demonstrated that using fluvoxamine to treat high-risk outpatients with early-diagnosed COVID-19 reduced the need for prolonged observation in an emergency setting or hospitalization, compared to a control group who received a placebo.

28 Oct 2021

Depression News and Research

Latest Depression News and Research

Democrats plan to expand Medicare hearing benefits. What can consumers expect?

APOL1 variant risk may extend to poorer outcomes from SARS-CoV-2 infection

Study finds significant increase in cannabis use disorder during pregnancy

Study shows aberrant changes over time in the brains of people with bipolar disorder

Study finds link between prior poor mental health and higher COVID-19 infection rates

Study finds high levels of anxiety, depression among medical doctors during COVID-19 pandemic

NIH to support a four-year study on long-term effects of COVID-19 in pregnancy

The impacts of the SARS-CoV-2 pandemic on digestive health

Merging AI with targeted electrical brain stimulation to improve specific human brain functions

Factors predicting cognitive symptoms in long COVID

Stanford neuromodulation therapy causes remission in almost 80% of patients with severe depression

Researchers receive $9.1 million grant to study resilience in older adults before and during the pandemic

Women in the military face a considerable risk of emotional bullying, sexual harassment and physical assault

Magnus Medical receives FDA's Breakthrough Device Designation for rapid-acting technology to treat major depression

Review finds great resilience in mental health during during COVID-19 pandemic

Using fluvoxamine to treat COVID-19 patients reduces the need for prolonged hospitalization, trial shows

COVID-19 and subacute neuropsychiatric symptoms in adolescents

Do pre-existing mental disorders and their co-occurrence affect COVID-19 clinical outcomes?

Postpartum women's experience of social restrictions during COVID-19

Repeated dopamine release in the brain plays a key role in infant social development

Innovation in neuroscience drug discovery - eBook eBook

Edoardo Fabini

Reducing polypharmacy through innovative drug formulation technologies

How innovation in dried blood spot testing is transforming neurological disease monitoring

Depression News and Research

Latest Depression News and Research

Innovation in neuroscience drug discovery - eBook eBook

Edoardo Fabini

Reducing polypharmacy through innovative drug formulation technologies

How innovation in dried blood spot testing is transforming neurological disease monitoring

Newsletters you may be interested in